DPA participates in various EU
projects and collaborations involving pharmaceutical policies and pricing and
reimbursement of medicines. This allows the exchange of information, best
practices and experiences regarding pharmaceutical policies on pricing and reimbursement,
health technology assessment and other pharmaceutical issues which are
routinely identified, shared and discussed.
DPA aims to:
- Participate
in various EU networks and initiatives relating to pharmaceutical policy.
- Communicate
and collaborate with EU peers involved in similar functions.
- Establish
contacts with pricing and reimbursement agencies and authorities across the EU.
- Continue
improving on various aspects related to pharmaceutical policy in Malta through
EU policy research and knowledge sharing.
- Review
EU related documents and reports to provide the necessary feedback and positions.
DPA collaborates and participates with a
wide range of international stakeholders on various projects. Some of these include:
A PPRI policy brief about the
Maltese pharmaceutical system can be accessed here.
https://www.eunethta.eu/
Pharmaceutical Strategy for
Europe
Network of Competent Authorities for
Pricing and Reimbursement (CAPR)
Member State Coordination Group on
HTA (HTACG) https://health.ec.europa.eu/health-technology-assessment/regulation-health-technology-assessment/member-state-coordination-group-hta-htacg_en
https://www.ispor.org/member-groups/councils-roundtables/health-technology-assessment-council/health-technology-assessment-roundtables